These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3772736)

  • 1. In vivo interaction of the enantiomers of disopyramide in human subjects.
    Giacomini KM; Nelson WL; Pershe RA; Valdivieso L; Turner-Tamiyasu K; Blaschke TF
    J Pharmacokinet Biopharm; 1986 Aug; 14(4):335-56. PubMed ID: 3772736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enantioselective steady-state kinetics of unbound disopyramide and its dealkylated metabolite in man.
    Hasselström J; Enquist M; Hermansson J; Dahlqvist R
    Eur J Clin Pharmacol; 1991; 41(5):481-4. PubMed ID: 1761078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of concentration-dependent binding to plasma proteins on the pharmacokinetics and pharmacodynamics of disopyramide.
    Giacomini KM; Blaschke TF
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():42-8. PubMed ID: 6705426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereoselective pharmacokinetics of disopyramide enantiomers in man.
    Lima JJ; Boudoulas H; Shields BJ
    Drug Metab Dispos; 1985; 13(5):572-7. PubMed ID: 2865105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human pharmacokinetics and metabolism of disopyramide enantiomers.
    Le Corre P; Gibassier D; Sado P; Le Verge R
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():233-7. PubMed ID: 1820885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide.
    Giacomini KM; Swezey SE; Turner-Tamiyasu K; Blaschke TF
    J Pharmacokinet Biopharm; 1982 Feb; 10(1):1-14. PubMed ID: 7069575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective pharmacokinetics of disopyramide and interaction with cimetidine.
    Bonde J; Pedersen LE; Nygaard E; Ramsing T; Angelo HR; Kampmann JP
    Br J Clin Pharmacol; 1991 Jun; 31(6):708-10. PubMed ID: 1867965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of disopyramide enantiomers for sites on plasma protein.
    Lima JJ
    Life Sci; 1987 Dec; 41(26):2807-13. PubMed ID: 3695808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective disposition and metabolism of disopyramide in pediatric patients.
    Echizen H; Takahashi H; Nakamura H; Ochiai K; Chiba K; Koike K; Ogata H; Ishizaki T
    J Pharmacol Exp Ther; 1991 Dec; 259(3):953-60. PubMed ID: 1762088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiarrhythmic activity and unbound concentrations of disopyramide enantiomers in patients.
    Lima JJ; Wenzke SC; Boudoulas H; Schaal SF
    Ther Drug Monit; 1990 Jan; 12(1):23-8. PubMed ID: 2305417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans.
    Le Corre P; Gibassier D; Sado P; Le Verge R
    Drug Metab Dispos; 1988; 16(6):858-64. PubMed ID: 2907466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics, protein binding and antiarrhythmic effects of disopyramide enantiomers in arrhythmic patients.
    Aso R; Ohashi K; Katoh T; Ogata H
    Int J Clin Pharmacol Res; 2001; 21(3-4):137-46. PubMed ID: 12067143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective pharmacokinetics and pharmacodynamics of disopyramide and its metabolite in rabbits.
    Horikawa M; Yasumuro M; Kanno M; Hanada K; Hashiguchi M; Ogata H
    J Pharm Pharmacol; 2001 Dec; 53(12):1621-8. PubMed ID: 11804392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical pharmacokinetics of levorotatory and racemic disopyramide, at steady state, following oral administration in patients with ventricular arrhythmias.
    Le Corre P; Gibassier D; Descaves C; Sado P; Daubert JC; Le Verge R
    J Clin Pharmacol; 1989 Dec; 29(12):1089-96. PubMed ID: 2482304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of disopyramide and its mono-N-dealkylated metabolite enantiomers in human plasma and urine by enantioselective high-performance liquid chromatography.
    Takahashi H; Tamura A; Ogata H; Masuhara K
    J Chromatogr; 1990 Aug; 529(2):347-58. PubMed ID: 2229254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS: Application in a pharmacokinetic study of a parturient with placental transfer.
    Souza MCO; Marques MP; Duarte G; Lanchote VL
    J Pharm Biomed Anal; 2019 Feb; 164():268-275. PubMed ID: 30399533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective binding of disopyramide to human plasma protein.
    Lima JJ; Jungbluth GL; Devine T; Robertson LW
    Life Sci; 1984 Aug; 35(8):835-9. PubMed ID: 6482678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of stereoselectivity on the pharmacokinetics and pharmacodynamics of antiarrhythmic drugs.
    Mehvar R; Brocks DR; Vakily M
    Clin Pharmacokinet; 2002; 41(8):533-58. PubMed ID: 12102640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodynamic and electrophysiologic effects of disopyramide enantiomers in a canine blood superfusion model.
    Kidwell GA; Lima JJ; Schaal SF; Muir WW
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):644-55. PubMed ID: 2471004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the enantiomers of disopyramide and its major metabolite on the electrophysiological characteristics of the guinea-pig papillary muscle.
    Vanhoutte F; Vereecke J; Carmeliet E; Verbeke N
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Dec; 344(6):662-73. PubMed ID: 1775199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.